NCT06404164 Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection
| NCT ID | NCT06404164 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Guangdong Provincial People's Hospital |
| Condition | Pulmonary Function Assessment |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2022-01-30 |
| Primary Completion | 2024-04-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2022-01-30 with a primary completion date of 2024-04-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A method of ICG counterstaining localization under target artery occlusion without cutting，It's a new method of localization of small pulmonary nodules.
Eligibility Criteria
Inclusion Criteria: 1. \<1cm CTR≤0.75; \<1.5cm CTR≤0.5; \<2cm CTR≤0.25 Lung nodules 2. The tumor center is located in the peripheral 2/3 area of the lung field 3. Preoperative analysis and planning of watershed by 3D reconstruction 4. Clinically assessed as cT1aN0M0 stage IA1/cT1bN0M0 stage IA2 (eighth edition), clinically resectable Exclusion Criteria: 1. No surgical video, no postoperative gross specimen and related distance measurement records 2. The incision edge does not exceed the target nodule diameter from the nodule edge 3. The resection range exceeds 50% of the preoperative planning 4. Postoperative pathological staging non-pT1aN0M0 IA1 stage/pT1bN0M0 IA2 stage (eighth edition) 5. Any situation where the investigator feels the need for extended resection 6. Patients with chronic diseases (such as COPD, pulmonary fibrosis, silicosis) that can cause loss of lung function in patients at risk of progression or potential progression
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06404164 clinical trial?
This trial is open to participants of all sexes, studying Pulmonary Function Assessment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06404164 currently recruiting?
Yes, NCT06404164 is actively recruiting participants. Contact the research team at 13609777314@163.com for enrollment information.
Where is the NCT06404164 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06404164 clinical trial?
NCT06404164 is sponsored by Guangdong Provincial People's Hospital. The trial plans to enroll 3,000 participants.